Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
125632431	12563243	1	I	20160308	20160712	20160715	20160715	EXP	IT-MINISAL02-366815	IT-MYLANLABS-2016M1029260	MYLAN		0.00				Y	0.00000		20160715		MD	IT	IT

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
125632431	12563243	1	PS	AMLODIPINE	AMLODIPINE BESYLATE	1	Oral	10 MG, QD	130	MG	Y	U			76418	10	MG	TABLET	QD
125632431	12563243	2	SS	OLMESARTAN MEDOXOMIL.	OLMESARTAN MEDOXOMIL	1		20 MG, QD	1360	MG	Y	U			0	20	MG	TABLET	QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
125632431	12563243	1	Hypertension
125632431	12563243	2	Hypertension

Outcome of event

Event ID	CASEID	OUTC COD
125632431	12563243	HO

Reactions reported

Event ID	CASEID	PT
125632431	12563243	Hyperhidrosis
125632431	12563243	Orthostatic hypotension
125632431	12563243	Syncope
125632431	12563243	Vision blurred

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
125632431	12563243	1	20160225	20160308	0
125632431	12563243	2	20160101	20160308	0